Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Government panel recommends Covovax inclusion in vaccine drive for those aged 12 and above
According to a source, a meeting of the COVID-19 Working Group was held on 1st April to review the data
EMA increases general, non-pharmacovigilance fees by 0.3 per cent and 5.3 per cent from 1st April,…
Every year, the agency adjusts its fees on 1st April, in line with the European Union (EU) inflation rate for the previous year
US FDA grants priority review to Roche’s Actemra/RoActemra to treat COVID-19 in hospitalised adults
If approved, Actemra/RoActemra would be the first US FDA-approved immunomodulator for the treatment of COVID-19 in hospitalised…
Pfizer’s bowel disease drug succeeds in second late-stage study
Pfizer's etrasimod showed improvement in patients with moderate-to-severe ulcerative colitis after 52 weeks. It met the twin main…
Russia registers nasal version of Sputnik V
In October 2021, the Health Ministry had issued the authorisation to the Gamaleya Center for the second phase of clinical trials…
US FDA approves Gilead cell therapy for earlier lymphoma
The one-time treatment was initially approved in 2017 for patients with large B-cell lymphoma who did not respond to at least two…
IPC has become more receptive and open to stakeholders
After having spent more than 20 years in corporate pharma, Dr Rajeev Singh Raghuvanshi, PhD, Secretary-cum-Scientific Director,…
Sanofi offers 1.5 billion euro bond linked to access to medicine
The company said the costs of financing would be linked to achieving concrete targets in terms of a cumulative number of patients…
Punjab government, Roche Pharma and Niramai Health Analytix launch ‘Pink Project’…
Programme to screen 15,000 suspected females within one year and help establish a referral pathway for follow-ups for diagnosis…
US House approves bill setting strict cap on insulin costs
The legislation would still have to be considered by the Senate, which is crafting a much broader bill